跳至主要内容
临床试验/NL-OMON52244
NL-OMON52244招募中不适用

The impact of optical coherence tomography on the decision-making process of endovascular treatment of femoropopliteal disease - Optimo study

Rijnstate Ziekenhuis0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Aged 18 years or older
  • Written informed consent
  • Scheduled endovascular treatment of femoropopliteal stenotic lesions with a
  • Supera or Absolute stent
  • Clinically and hemodynamically stable

排除标准

  • Occluded superficial femoral artery or popliteal artery
  • Superficial femoral artery and/or popliteal artery diameter larger than 6.5 mm
  • Severely impaired renal function (eGFR < 30 ml/min), end stage renal disease
  • Cardiac insufficiency (NYHA 3-4)
  • Hypersensitivity to iodinated contrast media
  • BMI > 25 and contralateral approach not possible
  • Minimal lumen diameter of target lesion < 1.5 mm
  • Presence of a hemodynamically significant inflow stenosis in the aorto-iliac
  • tract or the common femoral artery
  • Participating in another trial with an investigational drug or medical device
  • concerning the femoropopliteal tract, interfering with the current study
  • Life expectancy of less than 24 months
  • Woman of child-bearing age not on active birth control
  • Legally incapable

研究者

发起方
Rijnstate Ziekenhuis

相似试验

The impact of optical coherence tomography on the... | 临床试验